Accelerated Access Review

The government is currently undertaking the Accelerated Access Review, which is looking at ways to speed up access to innovative drugs, devices and diagnostics for NHS patients.

Emily and Alex made contributions on the views of patients at various workshops at the MHRA and at a series of discussions organised by the Centre for the Advancement of Sustainable Medical Innovation (CASMI), whose reports fed back to the Accelerated Access Review.

Feedback on the Interim report, was published in January 2016. 

Published on 12 December 2016

Share this article